Effect of zinc therapy on natural killer cell activity in inflammatory bowel disease. 1993

Y Van de Wal, and A Van der Sluys Veer, and H W Verspaget, and T P Mulder, and G Griffioen, and E A Van Tol, and A S Peña, and C B Lamers
Department of Gastroenterology and Hepatology, University Hospital Leiden, The Netherlands.

Disturbances in zinc metabolism have been documented in patients with inflammatory bowel disease. In this study we evaluated the effect of in vivo treatment with zinc on the in vitro natural killer cell activity in thirteen inflammatory bowel disease patients, with stable disease and mild-moderate disease activity, in a double-blind randomized cross-over trial. The results of our study show a long-lasting effect of in vivo zinc administration, which decreased peripheral blood natural killer cell activity in inflammatory bowel disease.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D003424 Crohn Disease A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. Colitis, Granulomatous,Enteritis, Granulomatous,Enteritis, Regional,Ileitis, Regional,Ileitis, Terminal,Ileocolitis,Crohn's Disease,Crohn's Enteritis,Inflammatory Bowel Disease 1,Regional Enteritis,Crohns Disease,Granulomatous Colitis,Granulomatous Enteritis,Regional Ileitides,Regional Ileitis,Terminal Ileitis
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Van de Wal, and A Van der Sluys Veer, and H W Verspaget, and T P Mulder, and G Griffioen, and E A Van Tol, and A S Peña, and C B Lamers
August 1986, Journal of clinical & laboratory immunology,
Y Van de Wal, and A Van der Sluys Veer, and H W Verspaget, and T P Mulder, and G Griffioen, and E A Van Tol, and A S Peña, and C B Lamers
September 1983, Clinical rheumatology,
Y Van de Wal, and A Van der Sluys Veer, and H W Verspaget, and T P Mulder, and G Griffioen, and E A Van Tol, and A S Peña, and C B Lamers
January 2019, The Egyptian journal of immunology,
Y Van de Wal, and A Van der Sluys Veer, and H W Verspaget, and T P Mulder, and G Griffioen, and E A Van Tol, and A S Peña, and C B Lamers
July 1983, Journal of clinical & laboratory immunology,
Y Van de Wal, and A Van der Sluys Veer, and H W Verspaget, and T P Mulder, and G Griffioen, and E A Van Tol, and A S Peña, and C B Lamers
October 2010, Pediatrics,
Y Van de Wal, and A Van der Sluys Veer, and H W Verspaget, and T P Mulder, and G Griffioen, and E A Van Tol, and A S Peña, and C B Lamers
October 1983, Gastroenterology,
Y Van de Wal, and A Van der Sluys Veer, and H W Verspaget, and T P Mulder, and G Griffioen, and E A Van Tol, and A S Peña, and C B Lamers
June 1988, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Y Van de Wal, and A Van der Sluys Veer, and H W Verspaget, and T P Mulder, and G Griffioen, and E A Van Tol, and A S Peña, and C B Lamers
October 1989, Immunology letters,
Y Van de Wal, and A Van der Sluys Veer, and H W Verspaget, and T P Mulder, and G Griffioen, and E A Van Tol, and A S Peña, and C B Lamers
January 1986, Archives of dermatological research,
Y Van de Wal, and A Van der Sluys Veer, and H W Verspaget, and T P Mulder, and G Griffioen, and E A Van Tol, and A S Peña, and C B Lamers
August 1992, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!